The European Commission approves isatuximab + VRd combination therapy for newly diagnosed, transplant ineligible myeloma patientsAccess, Myeloma, News24 January 2025
MPE at ASH 2024: key research and expert insights on myelomaAL amyloidosis, CAR-T, Conferences, MPE, Myeloma16 December 2024
Myeloma and AL amyloidosis ASH 2024 previewAccess, AL amyloidosis, CAR-T, MPE, Myeloma29 November 2024
MPE webinar on ASH 2024 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma, News29 November 2024
EMA CHMP gives positive opinion on isatuximab combination for newly diagnosed myeloma patientsAccess, Myeloma, News20 November 2024
Watch the webinar “Importance of good nutrition and healthy diet for young myeloma patients”Myeloma, Videos18 October 2024
During European Myeloma Day, MPE highlights the importance of improving access to clinical trialsAccess, MPE, Myeloma27 September 2024
EMA recommends a new indication for daratumumab in adult patients with newly diagnosed myeloma who are eligible for autologous stem cell transplantAccess, Myeloma26 September 2024
